Results 161 to 170 of about 38,233 (326)

The Role of Inflammation in Migraine Headaches: A Review

FASEB BioAdvances, Volume 7, Issue 7, July 2025.
Inflammation plays a crucial role in the onset and intensity of both migraine headache symptoms and attacks. Pro‐inflammatory neurotransmitters and mediators released from neural cells and tissues that contributes to increase in nitric oxide, increase in glutamate, alterations in serotonin and dopamine levels and pain perception are involved in ...
Caryn T. Morgan, Sanah M. Nkadimeng
wiley   +1 more source

Strategies for Treating Acute Migraines and Identifying Triggers. Literature review

Journal of Education, Health and Sport
Introduction Migraine, a prevalent neurological disorder affecting a substantial portion of the global population, poses a significant burden on individuals' overall quality of life.
Zuzanna Kotowicz, Jakub Pabiś, Piotr Podgórski, Sandra Górecka, Miłosz Olszański, Aleksander Bogusz, Oskar Kwiatkowski, Anna Kołodziej, Anita Król   +8 more
doaj   +1 more source

Migraine with Prolonged Aura: Correlation of Clinical and EEG Features

Behavioural Neurology, 1995
Migraine with prolonged aura has rarely been examined with regard to the sequence of the neurological symptoms and the associated EEG changes. This report describes five patients who underwent clinical assessment and EEG recordings during attacks of ...
A. O. Ogunyemi
doaj   +1 more source

Precipitating factors of migraine attacks in patients with migraine without aura [PDF]

, 2001
Ricardo Ierusalimschy
openalex   +1 more source

Wearable sensors in paediatric neurology

Developmental Medicine &Child Neurology, Volume 67, Issue 7, Page 834-853, July 2025.
Types of signals monitored in children's natural environments using wearable sensors, and their associated applications in various paediatric neurological conditions. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16267 Abstract Wearable sensors have the potential to transform diagnosis, monitoring, and management of children ...
Camila González Barral, Laurent Servais
wiley   +1 more source

Swiss Quality of Life and Health Care Impact Assessment in a Real‐World Erenumab‐Treated Migraine Population: Results over 2 years

Headache: The Journal of Head and Face Pain, Volume 65, Issue 7, Page 1134-1147, July/August 2025.
Abstract Objectives/Background This prospective, multicenter, noninterventional cohort study evaluated the impact of erenumab on the quality of life and migraine‐related impairment of adult patients with migraine, as well as the drug's tolerability in a real‐world setting over 2 years.
Andreas R. Gantenbein, Christian P. Kamm, Christoph J. Schankin, Chiara Zecca, Dominik Zieglgänsberger, Heiko Pohl, Philippe Ryvlin, Reto Agosti, Dragana Viceic, Catherine Parzini, Monika Kulartz‐Schank, Michael E. Arzt   +11 more
wiley   +1 more source

Identifying and predicting headache trajectories among those with acute post‐traumatic headache

Headache: The Journal of Head and Face Pain, Volume 65, Issue 7, Page 1124-1133, July/August 2025.
Abstract Objectives/Background Post‐traumatic headache (PTH) is a common symptom following mild traumatic brain injury (mTBI). Currently, there is no identified way to accurately predict if, when, and at what pace a person will have PTH improvement. In our prior studies, we focused on predicting headache improvement at 3 months post‐mTBI. However, that
Lingchao Mao, Jing Li, Todd J. Schwedt, Teresa Wu, Katherine Ross, Gina Dumkrieger, Dani C. Smith, Catherine D. Chong   +7 more
wiley   +1 more source

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab

Headache: The Journal of Head and Face Pain, Volume 65, Issue 7, Page 1080-1094, July/August 2025.
Abstract Objectives/Background This study was undertaken to evaluate the postmarketing safety of monoclonal antibodies (mAbs) targeting the calcitonin gene‐related peptide pathway used for migraine prophylaxis through pharmacovigilance data analysis by examining suspected adverse events reported in Europe.
Victoria Nikitina, Greta Santi Laurini, Nicola Montanaro, Domenico Motola   +3 more
wiley   +1 more source

Cardiovascular risk and triptan usage among patients with migraine

Headache: The Journal of Head and Face Pain, Volume 65, Issue 7, Page 1095-1106, July/August 2025.
Abstract Background Migraine, a neurovascular disorder evident by recurrent headaches, is associated with increased risk of ischemic vascular events, including ischemic stroke and myocardial infarction. Triptans, acute migraine‐specific treatment, cause vasoconstriction, complicating treatment decisions, especially for patients with migraine with ...
Ido Peles, Ruth Smadar Shneyour, Eran Levanon, Yana Mechnik Steen, Ibraheem Abu Salameh, Michal Gordon, Ran Abuhasira, Victor Novack, Gal Ifergane   +8 more
wiley   +1 more source

Platelet-Activating Factor (PAF) in Internal Jugular Venous Blood of Migraine without aura Patients Assessed during Migraine Attacks [PDF]

, 2004
Paola Sarchielli, Andrea Alberti, Francesca Coppola, Antonio Baldi, Beatrice Gallai, Al Floridi, A. Floridi, Giuseppe Capocchi, Virgilio Gallai   +8 more
openalex   +1 more source